Mortality of Malignant Melanoma in Central Serbia, in the Period 1999-2015.


Journal

Dermatology practical & conceptual
ISSN: 2160-9381
Titre abrégé: Dermatol Pract Concept
Pays: Austria
ID NLM: 101585990

Informations de publication

Date de publication:
01 01 2023
Historique:
aheadofprint: 01 01 2023
accepted: 20 06 2022
entrez: 9 3 2023
pubmed: 10 3 2023
medline: 10 3 2023
Statut: epublish

Résumé

Malignant melanoma is one of the rarest forms of skin cancer but it is the most deadly. The objective of this paper was to analyze the epidemiological characteristics and trends of mortality from malignant melanoma in the population of Central Serbia in the period 1999-2015. The study was designed as a retrospective descriptive epidemiological study. Standardized mortality rates were used in statistical data processing. A linear trend model and regression analysis were used to examine trends in malignant melanoma mortality. In Serbia, malignant melanoma mortality shows an increasing trend. The overall age-adjusted melanoma death rate was 2.6 per 100,000 with a higher death rate among men (3.03 per 100,000) than among women (2.1 per 100,000). Malignant melanoma mortality rates increase with age in both sexes and are highest in the age group of 75 and older. The highest increase in mortality in men is recorded in the 65-69 age group, with an average percentage increase of 21.33 (95% CI, 8.40 - 51.05), while in women the largest increase in mortality was recorded in the 35-39 age group, with an average percentage increase of 31.4 and in the 70-74 age group, 12.9. The trend of increasing mortality from malignant melanoma in Serbia is similar to those in most developed countries. Education and improvement of awareness in the general population and among health professionals are vital to reducing melanoma mortality in the future.

Identifiants

pubmed: 36892369
pii: dpc.1301a8
doi: 10.5826/dpc.1301a8
pmc: PMC9946065
doi:

Types de publication

Journal Article

Langues

eng

Références

Postepy Dermatol Alergol. 2016 Dec;33(6):421-428
pubmed: 28035218
Int J Cancer. 2018 Apr 15;142(8):1528-1535
pubmed: 29105744
Cancer Causes Control. 2007 Apr;18(3):295-304
pubmed: 17206532
Br J Dermatol. 2014 Jan;170(1):11-9
pubmed: 23815297
Oncotarget. 2014 Mar 30;5(6):1439-51
pubmed: 24742402
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S38-49
pubmed: 22018066
Int J Cancer. 2015 Feb 1;136(3):603-9
pubmed: 24806428
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):111-20
pubmed: 20056629
J Hematol Oncol. 2019 Sep 12;12(1):96
pubmed: 31511035
Clin Dermatol. 2009 Jan-Feb;27(1):3-9
pubmed: 19095149
Br J Dermatol. 2001 Mar;144(3):471-5
pubmed: 11260001
Am J Public Health. 2016 Sep;106(9):1677-83
pubmed: 27459457
J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1522-1528
pubmed: 30868690
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Melanoma Res. 2010 Jun;20(3):163-70
pubmed: 20375923
J Gastrointestin Liver Dis. 2014 Sep;23(3):267-71
pubmed: 25267954
Adv Exp Med Biol. 2008;624:89-103
pubmed: 18348450
Prev Med. 2016 Oct;91:294-298
pubmed: 27565055
Exp Dermatol. 2006 Dec;15(12):971-80
pubmed: 17083364
J Cutan Med Surg. 2019 Jul/Aug;23(4):394-412
pubmed: 31132871
Expert Rev Anticancer Ther. 2010 Nov;10(11):1811-23
pubmed: 21080806
Ann Oncol. 2009 Feb;20(2):358-64
pubmed: 18725391
BMC Cancer. 2013 Aug 06;13:372
pubmed: 23915380
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S17-25.e1-3
pubmed: 22018063
Arch Dermatol Res. 2015 Oct;307(8):731-40
pubmed: 26103951
J Am Acad Dermatol. 2014 Dec;71(6):1137-1143.e17
pubmed: 25282129
J Invest Dermatol. 2016 Jun;136(6):1161-1171
pubmed: 26902923
Eur J Cancer. 2005 Sep;41(14):2040-59
pubmed: 16125929
Br J Dermatol. 2017 Jul;177(1):134-140
pubmed: 28369739
MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):591-6
pubmed: 26042651
Adv Exp Med Biol. 2014;810:120-40
pubmed: 25207363

Auteurs

Milica Pantovic (M)

Clinical Hospital Center Zemun, Belgrade, Serbia.

Ognjen Djordjevic (O)

Department of Hygiene and Ecology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Svetlana Radevic (S)

Department of Social Medicine, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Dragic Bankovic (D)

Faculty of Science, University of Kragujevac, Kragujevac, Serbia.

Katarina Parezanovic Ilic (KP)

University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Physical medicine and rehabilitation.

Snezana Radovanovic (S)

Department of Social Medicine, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Classifications MeSH